Moreover, diverse papillary thyroid cancer cell lines harboring RET/PTC rearrangements or BRAF V600E mutation had higher osteopontin expression in comparison to normal thyroid cells. The gene discussed is RET; the disease is thyroid gland papillary carcinoma.